- Shopping Bag ( 0 items )
From The CriticsReviewer: Natalie M Webster, MD(University of Kansas Medical Center)
Description: In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. It presents pertinent clinicopathologic background for each cancer type, including an introduction, incidence and mortality, and clinical presentation, in addition to the well-synthesized biomolecular research that is occurring in the realm of biotargets and targeted therapies.
Purpose: "This purpose is to provide an update on biotargets of cancer to those involved in the care of oncology patients, ranging from medical students to oncologists and pathologists. This book includes, for each organ system and cancer type, a thorough yet concise discussion of epidemiology, biomarkers for diagnosis, description of genes relevant to prognosis, and therapy through biotarget-specific new molecules. These are important objectives, as personalized medicine comes to the forefront of patient care, and this book consistently meets them. "
Audience: According to the editor, the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists.
Features: "This book discusses each major cancer type and includes a comprehensive yet concise discussion of epidemiological factors, biomarkers for diagnosis, descriptions of relevant genes used to determine prognosis, and potential for individualized therapies. The best feature of this book is the way it focuses on each major cancer type and discusses all of these aspects in a thorough yet concise manner. It is also helpful to have a concise discussion regarding the biotargets of each individual tumor and how that is translated into clinical practice, including individualized therapies. The book lacks color art, but the diagrams and illustrations are well done and easy to read. "
Assessment: This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. It would be easy to get carried away and create a book that is exhaustive and difficult to read, as many authors do. However, this book achieves its objectives while remaining easy to read.